Valeant Calls Allergan's Insider Trading Claims A Stunt
By Kaitlyn Kiernan ( August 15, 2014, 2:23 PM EDT) -- Valeant Pharmaceuticals International Inc. denounced on Thursday Allergan Inc.'s insider trading accusations in a California federal court as a ruse to delay a separate case in Delaware in which Valeant is looking to force Allergan — the target of a hostile $53 billion takeover bid — to call a special shareholders meeting....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.